PL can increase reactive oxygen species (ROS) levels and apoptotic cell death in both cancer cells and normal cells engineered to have a cancer genotype, irrespective of the p53 status, with little effect on either rapidly or slowly dividing primary normal cells [10]. Here, TP53 is linked to cancer.